ASCEND-3: A Single-Arm, Open-Label, Multicenter Phase II Study of Ceritinib in ALKi-naive Adult Patients (pts) with ALK-Rearranged (ALK+) Non-Small Cell Lung Cancer (NSCLC)
Invited conference paper presented and published in conference proceedings

香港中文大學研究人員

其它資訊
著者FELIP Enriqueta, ORLOV Sergey, PARK Keunchil, YU Chong Jen, TSAI Chun Ming, NISHIO Makoto, DOLS Manuel Cobo, MCKEAGE Mark James, SU Wu Chou, MOK Shu Kam Tony, SCAGLIOTTI Giorgio V, SPIGEL David, BRANLE Fabrice, EMEREMNI Chetachi, QUADRIGLI Massimiliano, SHAW Alice Tsang
會議名稱ASCO 2015 Annual Meeting
會議開始日29.05.2015
會議國家/地區美國
會議論文集題名ASCO 2015 Annual Meeting
出版年份2015
月份5
日期29
出版地United States of America, Chicago
頁次Board #383, abstr 8060
語言英式英語
關鍵詞ALK+; NSCLC

上次更新時間 2018-22-01 於 16:18